Sertraline can reduce the uremic pruritus in hemodialysis patient: A double blind randomized clinical trial from Southern Iran
Abstract Introduction: Uremic pruritus is an undesirable complication of end stage renal disease (ESRD). In spite of introduction of many treatments for this complication, it has no certain cure. The aim of this study was to assess sertraline effect on uremic pruritus. Methods: In the present clinical trial study, we randomly divided our patients into two groups; trial group that received sertraline and control group that consumed placebo. We measured the severity of pruritus by two scoring systems (visual analogue scale and DUO) at the beginning and during the study with a‐2‐week interval. Data were analyzed by SPSS 18.0 and a P value
Preoperative ultrasound vessel mapping is a crucial step in operative planning for permanent hemodialysis access creation. Whereas the majority of the focus remains on vein caliber, anatomic arterial variants are often overlooked. Despite being a relatively common variation, little is known about the impact of a high brachial bifurcation on hemodialysis access outcomes. Our goal was to examine the relationship between a high brachial bifurcation and arteriovenous fistula (AVF) maturation and patency in patients undergoing upper arm hemodialysis access placement.
This study investigated a wearable device that enables remote monitoring of AVF function as well as physiologic parameters. The aim of the study was to evaluate the ability of the device to assess AVF function as well as to measure hemoglobin (Hgb) and hematocrit (Hct), markers that can have an impact on dialysis fluid management.
Owing to the lack of comparative evidence between the endovascular technologies for arteriovenous fistula (AVF) stenosis treatments, we sought to summarize the reported data comparing the effectiveness of different endovascular approaches for the treatment of AVF stenoses at the juxta-anastomotic site.
To report results from the Ellipsys EndoAVF registry
Vascular access issues are an important cause of morbidity within the hemodialysis population, with significant associated health care costs related to dialysis access stenosis. Previous studies have demonstrated the beneficial role of endovascular drug coated balloon angioplasty (DCB) procedures in de novo hemodialysis access stenosis complications. However, there is limited data that directly compares the longevity of DCB and plain old balloon angioplasty (POBA) interventions in stenotic hemodialysis access lesions in patients with single preceding POBA intervention.
To assess the use of the self-expanding COVERA Vascular Covered Stent to treat stenotic lesions at the venous anastomosis of upper extremity hemodialysis arteriovenous (AV) grafts.
To assess the results using the ePTFE-covered, self-expanding COVERA Vascular Covered Stent for the treatment of stenotic lesions in the venous outflow of upper extremity hemodialysis arteriovenous (AV) fistulae.
To determine safety and efficacy of hemodialysis catheters placed via the internal jugular vein (IJV) in patients with total artificial heart (TAH) in the interventional radiology suite. Many proceduralists choose to place central lines via a femoral approach, as prior case reports have illustrated complications of central lines placed via the IJV in patients with TAH.
To evaluate the use of Intravascular ultrasound to identify the incidence of thrombus associated with tunneled hemodialysis catheters, during exchange of said malfunctioning catheters.
To determine the efficacy and outcome of percutaneous angioplasty (PTA) of palmar arch in patients with radiocephalic arteriovenous fistulas (AVFs) with occluded feeding artery